Pamidronate does not adversely affect bone intrinsic material properties in children with osteogenesis imperfecta
- 28 April 2006
- Vol. 39 (3) , 616-622
- https://doi.org/10.1016/j.bone.2006.02.071
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Differential effects of alendronate treatment on bone from growing osteogenesis imperfecta and wild-type mouseBone, 2005
- Two different correlations between nanoindentation modulus and mineral content in the bone–cartilage interfaceJournal of Structural Biology, 2004
- Structure and mechanical quality of the collagen–mineral nano-composite in boneJournal of Materials Chemistry, 2004
- Bone Mass, Size, and Density in Children and Adolescents With Osteogenesis Imperfecta: Effect of Intravenous Pamidronate TherapyJournal of Bone and Mineral Research, 2003
- The Role of the α2 Chain in the Stabilization of the Collagen Type I Heterotrimer: A Study of the Type I Homotrimer in oim Mouse TissuesJournal of Molecular Biology, 2002
- Collagen from the osteogenesis imperfecta mouse model (oim) shows reduced resistance against tensile stress.Journal of Clinical Investigation, 1997
- Bone mineralization in an osteogenesis imperfecta mouse model studied by small-angle x-ray scattering.Journal of Clinical Investigation, 1996
- An improved technique for determining hardness and elastic modulus using load and displacement sensing indentation experimentsJournal of Materials Research, 1992
- Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committeeJournal of Bone and Mineral Research, 1987
- Osteogenesis IrnperfectaPublished by Wolters Kluwer Health ,1987